欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号
PT/H/1325/001
药品名称
Rupatadina Substipharm
活性成分
rupatadine fumarate 10.0 mg
剂型
Tablet
上市许可持有人
Substipharm développement
参考成员国 - 产品名称
Portugal (PT)
互认成员国 - 产品名称
Netherlands (NL)
Rupatadine Substipharm 10 mg tabletten
Spain (ES)
Italy (IT)
许可日期
2016/01/20
最近更新日期
2024/03/25
药物ATC编码
R06AX28 rupatadine
申请类型
TypeLevel1:
Abridged
TypeLevel2:
Initial Application
TypeLevel3:
Generic Art 10.1 and 10.2 Dir 2001/83/EC
TypeLevel4:
Chemical Substance
TypeLevel5:
Prescription Only
附件文件下载
PubAR
|
5889655_20160415_PAR_GBB
Date of last change:2024/09/06
PubAR
|
588966_20160415_PAR_GBB
Date of last change:2024/09/06
PubAR
|
599482_20160415_PAR_GBB
Date of last change:2024/09/06
PubAR
|
599484_20160415_PAR_GBB
Date of last change:2024/09/06
PubAR
|
600235_20160415_PAR_GBB
Date of last change:2024/09/06
Final Product Information
|
common_impack
Date of last change:2024/09/06
Final Product Information
|
common_outer_clean205
Date of last change:2024/09/06
Final Product Information
|
common_pl_cleand205
Date of last change:2024/09/06
Final Product Information
|
common_spc_cleand205
Date of last change:2024/09/06
市场状态
Positive
©2006-2025
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase